CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Prognostic Factors of Second and Third Line Chemotherapy Using 5-FU with Platinum, Irinotecan, and Taxane for Advanced Gastric Cancer
Ji Soo Park, Jae Yun Lim, Seung Kyo Park, Min Kyung Kim, Hee Sung Ko, Sun Och Yoon, Jong Won Kim, Seung Ho Choi, Jae Yong Cho
Cancer Research and Treatment. 2011;43(4):236-243.   Published online 2011 December 27    DOI: https://doi.org/10.4143/crt.2011.43.4.236

Excel Download

Prognostic Factors of Second and Third Line Chemotherapy Using 5-FU with Platinum, Irinotecan, and Taxane for Advanced Gastric Cancer
Cancer Research and Treatment. 2011;43(4):236-243   Crossref logo
Link1 Link2

Irinotecan combined with 5-fluorouracil and leucovorin third-line chemotherapy after failure of fluoropyrimidine, platinum, and taxane in gastric cancer: treatment outcomes and a prognostic model to predict survival
Gastric Cancer. 2012;16(4):581-589   Crossref logo
Link1 Link2 Link3

P-088 Evaluation of prognostic and predictive factors in second-line treatment with irinotecan based chemotherapy in gastric cancer
Annals of Oncology. 2015;26:iv25   Crossref logo
Link1 Link2 Link3

P-072 Overall survival (OS) of patients with advanced gastric cancer (AGC) according to the availability of 5-FU, platinum, taxanes and irinotecan as first, second and third-line chemotherapy
Annals of Oncology. 2015;26:iv20   Crossref logo
Link1 Link2 Link3

Second-line chemotherapy using taxane in patients with advanced gastric cancer who presented with severe peritoneal metastasis: A multicenter retrospective study
. 2019;   Crossref logo
Link1 Link2

Second-line chemotherapy for patients with advanced gastric cancer
Gastric Cancer. 2017;20(3):395-406   Crossref logo
Link1 Link2 Link3

Third-Line Weekly Docetaxel Chemotherapy in Advanced Gastric Cancer Who Failed Previous Fluoropyrimidine and Irinotecan or Oxaliplatin-Based Chemotherapies
Annals of Oncology. 2014;25:iv230   Crossref logo
Link1 Link2 Link3

Irinotecan monotherapy as third-line treatment for advanced gastric cancer refractory to fluoropyrimidines, platinum, and taxanes
Gastric Cancer. 2016;20(4):655-662   Crossref logo
Link1 Link2 Link3

Association of fluoropyrimidines, platinum agents, taxanes, and irinotecan in any line of chemotherapy with survival in patients with advanced gastric cancer
Gastric Cancer. 2011;14(2):155-160   Crossref logo
Link1 Link2 Link3 Link4

Phase Ib study of irinotecan and ramucirumab for advanced gastric cancer previously treated with fluoropyrimidine with/without platinum and taxane
Cancer Chemotherapy and Pharmacology. 2018;82(5):839-845   Crossref logo
Link1 Link2 Link3

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.